In this Bioanalysis Zone interview, Pegah Jalili (MilliporeSigma; MA, USA) discusses her work in analytical R&D supporting biotherapeutic characterization and quantification. Pegah explains the advantages and disadvantages of techniques she uses in her research including ligand binding assays and LC–MS assays, before sharing her thoughts on the advances in automation she expects to see in the coming years.
If you are interested in biotherapeutics, you might also like…
Pegah Jalili’s insight into biomarker discovery (MilliporeSigma)
Developing bioanalytical LC–MS/MS methods for biotherapeutics and biomarkers: an interview with William Mylott
LC–MS for biotherapeutics research: an interview with Timothy Olah